A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
To assess the changes in the trough Systolic Blood Pressure (SBP) and the percent changes in
 Low Density Lipoprotein-Cholesterol (LDL-C) from baseline at Week 8 in the treatment period
Inclusion Criteria:

 -  The out-patient with concurrent hypertension and hyper-LDL-cholesterolemia is a male
 or female >=20 to <80 years of age at Visit 1.

 -  The SBP at Visit 4 (Week -1) and Visit 5 (Week 0) is continuously SBP >=140 mmHg and
 <180 mmHg,

 -  LDL-C >=140 mg/dL and <250 mg/dL at Visit 3 (Week -2) and 4 (Week -1).

 Exclusion Criteria:

 -  Subjects who had experienced the following coronary artery disease within the past 3
 months.

 -  Myocardial infarction

 -  Receiving PCI（percutaneous coronary intervention）or CABG (coronary artery bypass
 grafting)

 -  Any clinically meaningful valvular disease

 -  Subjects with a history of cerebrovascular diseases such as stroke or transient
 ischemic attack within the past 3 months.